NOVONIX Ltd Files Routine 6-K Report
Ticker: NVNXF · Form: 6-K · Filed: Oct 10, 2025 · CIK: 1859795
Sentiment: neutral
Topics: sec-filing, routine-report, foreign-private-issuer
TL;DR
NOVONIX filed a 6-K, just routine paperwork for foreign issuers. No big news.
AI Summary
NOVONIX Limited filed a Form 6-K on October 10, 2025, reporting for the month of October 2025. The company, based in Brisbane, Australia, is a foreign private issuer and files annual reports under Form 20-F. The filing does not contain specific financial figures or operational updates beyond its routine reporting status.
Why It Matters
This filing indicates NOVONIX is fulfilling its regular reporting obligations as a foreign private issuer with the SEC, which is standard for maintaining its public listing.
Risk Assessment
Risk Level: low — This is a routine filing by a foreign private issuer and does not contain new material information or financial disclosures.
Key Players & Entities
- NOVONIX Ltd (company) — Registrant
- SEC (company) — Securities and Exchange Commission
FAQ
What type of filing is this?
This is a Form 6-K, a Report of Foreign Private Issuer.
Who is the registrant?
The registrant is NOVONIX Limited.
Where is NOVONIX Limited based?
NOVONIX Limited is based in Brisbane, Australia.
Does NOVONIX file annual reports under Form 20-F or 40-F?
NOVONIX files annual reports under cover of Form 20-F.
What period does this 6-K report cover?
This Form 6-K reports for the month of October, 2025.
Filing Stats: 194 words · 1 min read · ~1 pages · Grade level 12.9 · Accepted 2025-10-10 06:32:36
Filing Documents
- nvx-6k-oct-2025-10-10-ap.htm (6-K) — 22KB
- nvx-ex99_1.htm (EX-99.1) — 101KB
- img58969013_0.jpg (GRAPHIC) — 1KB
- 0001193125-25-236380.txt ( ) — 125KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NOVONIX LIMITED By: /s/ Robert Long Robert Long Chief Financial Officer 1. Date: October 10, 2025